Tokyo, Japan and London, UK, 1 November 2018 – Sosei Group Corporation (“Sosei” or “the Company”; TSE Mothers Index: 4565) a world-leading GPCR medicine design and development companies, has appointed Mr Chris Cargill as Executive Vice President and Chief Financial Officer (CFO) with immediate effect. Mr Cargill was appointed Interim CFO in June 2018 having previously been a Senior Vice President in the Company.
Mr. Cargill joined Sosei in September 2017. Prior to joining Sosei, Mr. Cargill spent nearly a decade in Investment Banking at J.P. Morgan and held various positions of increasing responsibility, most recently as Vice President in the U.K. Corporate Finance Group, focused on the Healthcare sector. He began his career in the Corporate Finance division of KPMG, the global network of Audit, Tax, and Advisory firms.
1. Name and title
Name: Chris Cargill
Title: Executive Vice President and CFO
2. Brief summary
Date of Birth Profile Ownership of Shares of Sosei
3 January 1984 • February 2009 - February 2010: Analyst at KPMG
• April 2010 - July 2017: Analyst, Associate, Vice President at J.P. Morgan Chase & Co.
• September 2017 - present: SVP and EVP at Sosei Group Corporation 0
3. Effective date
As of 1 November 2018